Clinical Trials Logo

Symptoms of Inhalational Anthrax clinical trials

View clinical trials related to Symptoms of Inhalational Anthrax.

Filter by:
  • None
  • Page 1

NCT ID: NCT00448253 Completed - Clinical trials for Symptoms of Inhalational Anthrax

Safety and Pharmacokinetic Study of Anthrax Immune Globulin Derived From Human Serum

Start date: July 2007
Phase: Phase 1
Study type: Interventional

The purpose of the study is to assess the pharmacokinetics of three doses of NP-015 (210, 420 or 840 units TNA) in healthy volunteers. To evaluate the safety of NP-015 based on adverse events and laboratory assessments. To determine the dose proportionality relation of three different doses of NP-015.